STAB

Statera Biopharma, Inc. Common Stock
STAB

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

STAB was delisted on the 11th of January, 2023.

Back to rankings

19 hedge funds and large institutions have $715K invested in Statera Biopharma, Inc. Common Stock in 2015 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
19
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$81.4K
2
+$51K
3
+$23.5K
4
TDC
Thompson Davis & Co
Virginia
+$8K
5
Wells Fargo
Wells Fargo
California
+$1.94K

Top Sellers

1
-$71K
2
-$50.6K
3
-$18.7K
4
Citigroup
Citigroup
New York
-$7K
5
Bank of America
Bank of America
North Carolina
-$107
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$385K
2
$158K
3
$51K
4
$48K
5
$45K
6
$12K
7
$8K
8
$3K
9
$3K
10
$1K
11
$1K
12
–
13
–